Trials / Recruiting
RecruitingNCT05877781
PEA in Functional Dyspepsia
THE EFFECT OF DIETARY SUPPLEMENTATION WITH PALMITOYLETHANOLAMIDE ON GASTROINTESTINAL SYMPTOMS IN FUNCTIONAL DYSPEPSIA PATIENTS.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this placebo controlled randomized double blind interventional study is to assess the effect of palmitoylethanolamide supplementation in patients with functional dyspepsia The main questions it aims to answer are: * The efficacy of PEA on functional dyspepsia symptoms measured using the LPDS questionnaire * The effect of PEA on duodenal mucosal permeability. Participants will receive an 8-week during treatment with PEA 3x400 mg per day or placebo 3 times per day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Palmitoylethanolamide | 8-week treatment 3x400 mg per day |
Timeline
- Start date
- 2021-11-29
- Primary completion
- 2025-01-01
- Completion
- 2025-03-01
- First posted
- 2023-05-26
- Last updated
- 2024-07-01
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05877781. Inclusion in this directory is not an endorsement.